Provided by Tiger Fintech (Singapore) Pte. Ltd.

BriaCell Therapeutics Corp.

2.86
-0.0800-2.72%
Post-market: 2.860.00000.00%19:54 EDT
Volume:96.04K
Turnover:278.46K
Market Cap:19.38M
PE:-0.41
High:2.95
Open:2.94
Low:2.85
Close:2.94
Loading ...

BriaCell Jumps 41% in U.S. Pre-market Trading, Reports Complete Lung Metastasis Resolution in Patient

MT Newswires
·
24 Apr

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™

GlobeNewswire
·
24 Apr

Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

Benzinga
·
23 Apr

BriaCell Therapeutics: Promising Phase 3 Trial Progress and Strategic Financial Management Justify Buy Rating

TIPRANKS
·
22 Apr

BriaCell announces ongoing Phase 3 study enrolled over 75 patients

TIPRANKS
·
22 Apr

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

GlobeNewswire
·
22 Apr

BriaCell Therapeutics Stock Rises on Data for Late Stage Breast Cancer Treatment

Dow Jones
·
17 Apr

BriaCell Says Breast Cancer Therapy Shows Positive Survival Data; Shares Rise

MT Newswires Live
·
16 Apr

BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer

GlobeNewswire
·
16 Apr

BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3

GlobeNewswire
·
10 Apr

BriaCell to Showcase Cancer Immunotherapy Advances at AACR 2025

TIPRANKS
·
26 Mar

BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference

GlobeNewswire
·
26 Mar

BriaCell Therapeutics Says Data Safety Monitoring Board Recommends Continuation of Phase 3 Trial in Metastatic Breast Cancer

MT Newswires Live
·
20 Mar

Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire
·
20 Mar

Briacell Therapeutics Corp reports results for the quarter ended January 31 - Earnings Summary

Reuters
·
18 Mar

Briacell Therapeutics Corp expected to post a loss of $1.12 a share - Earnings Preview

Reuters
·
15 Mar

Wedbush Initiates BriaCell Therapeutics at Outperform With $15 Price Target

MT Newswires Live
·
25 Feb

BriaCell Announces Positive Shareholder Meeting Results

TIPRANKS
·
06 Feb

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

GlobeNewswire
·
06 Feb

BriaCell Therapeutics Secures $3.05 Million in Public Offering

TIPRANKS
·
06 Feb